Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
MEDIROM MOTHER Labs Partners with NFES Technologies Inc., M3, Inc., and Elematec Corporation for Series A Financing Round
Dec 16, 2024•over 1 year ago
Contract Type
partnership
Minato CitySoftwareHealth CareDescription
MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM Healthcare Technologies Inc., has raised an aggregate total of 260.3 million yen in its ongoing Series A equity financing round. NFES Technologies Inc., M3, Inc., Elematec Corporation, and certain individual investors are participating in the financing round. The pre-money equity valuation of 9 billion yen further validates the technology, business model, and growth potential of the MOTHER Bracelet®.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months